Neonatal screening for congenital cytomegalovirus infection in preterm and small for gestational age infants

F Lorenzoni1, S Lunardi, A Liumbruno

  • 1Neonatal Unit and Neonatal Intensive Care Unit, Department of Clinical and Experimental Medicine, University Hospital of Pisa , Pisa , Italy and.

Insights

Congenital cytomegalovirus (CMV) infection is a major cause of hearing loss in newborns. Early screening for CMV in preterm or small for gestational age infants is crucial for timely intervention.

Area of Science:

  • Virology
  • Neonatology
  • Public Health

Background:

  • Congenital cytomegalovirus (CMV) infection is a significant concern in newborns, impacting multiple organs, notably the reticuloendothelial and central nervous systems.
  • It is the primary non-genetic cause of sensorineural hearing loss, which may manifest at birth or develop later.
  • Congenital CMV infection is linked to adverse pregnancy outcomes, including stillbirth, preterm birth, and small for gestational age (SGA) conditions.

Purpose of the Study:

  • To investigate the association between congenital CMV infection and adverse neonatal outcomes such as preterm birth and SGA.
  • To advocate for early identification of congenital CMV infection in at-risk newborns due to the lack of a standardized large-scale screening method.

Main Methods:

  • The study analyzed the incidence of congenital CMV infection in newborns.
  • Specific focus was placed on identifying correlations with preterm birth and SGA status.

Main Results:

  • A statistically significant association was observed between congenital CMV infection and preterm births (3.03%).
  • Congenital CMV infection was also found to be associated with SGA condition (3.7%).

Conclusions:

  • Routine CMV urine detection is recommended for all infants born before 37 weeks of gestational age.
  • Screening for CMV should also be implemented in term SGA newborns to facilitate early diagnosis and management.